Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial
Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study's recruitment status is updated to not enrolling, and new navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention/Treatment label formatting was standardized.SummaryDifference0.6%

- Check20 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a newer version of the page metadata.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label in the page footer updated to v3.5.4, replacing v3.5.3. This change reflects a recent site/template update without altering study information.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, indicating a technical UI release rather than a change to the study content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe site revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedGlycogen storage disease II was updated to Glycogen storage disease, type II in the page's terminology (MeSH/keywords).SummaryDifference0.1%

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.